A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...
Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback